国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
12期
1441-1443
,共3页
无创正压通气%COPD%急性加重期%呼吸衰竭
無創正壓通氣%COPD%急性加重期%呼吸衰竭
무창정압통기%COPD%급성가중기%호흡쇠갈
Metoprolol%Chronic congestive heart failure%Efficacy
目的 探讨无创正压治疗COPD急性加重期伴呼衰的临床疗效.方法 选择2007年1月-2009年12月收治于我院的COPD急性加重期伴呼衰患者92例,随机分为观察组(46例)和对照组(46例),对照组采用常规疗法治疗;治疗组在常规治疗的基础上加用无创正压通气治疗.比较两组治疗效果.结果 观察组在治疗后PaCO2(42.24±6.22)mmHg、呼吸频率(21.2±1.3)次/分、PaO2(89.26±9.27)mmHg,治疗效果显著优于对照组(P<0.05).结论 无创正压通气治疗COPD急性加重期伴呼衰患者,能有效的降低PaCO2、呼吸频率和提高PaO2等,具有较好的临床疗效.
目的 探討無創正壓治療COPD急性加重期伴呼衰的臨床療效.方法 選擇2007年1月-2009年12月收治于我院的COPD急性加重期伴呼衰患者92例,隨機分為觀察組(46例)和對照組(46例),對照組採用常規療法治療;治療組在常規治療的基礎上加用無創正壓通氣治療.比較兩組治療效果.結果 觀察組在治療後PaCO2(42.24±6.22)mmHg、呼吸頻率(21.2±1.3)次/分、PaO2(89.26±9.27)mmHg,治療效果顯著優于對照組(P<0.05).結論 無創正壓通氣治療COPD急性加重期伴呼衰患者,能有效的降低PaCO2、呼吸頻率和提高PaO2等,具有較好的臨床療效.
목적 탐토무창정압치료COPD급성가중기반호쇠적림상료효.방법 선택2007년1월-2009년12월수치우아원적COPD급성가중기반호쇠환자92례,수궤분위관찰조(46례)화대조조(46례),대조조채용상규요법치료;치료조재상규치료적기출상가용무창정압통기치료.비교량조치료효과.결과 관찰조재치료후PaCO2(42.24±6.22)mmHg、호흡빈솔(21.2±1.3)차/분、PaO2(89.26±9.27)mmHg,치료효과현저우우대조조(P<0.05).결론 무창정압통기치료COPD급성가중기반호쇠환자,능유효적강저PaCO2、호흡빈솔화제고PaO2등,구유교호적림상료효.
Objective To explore the efficay of metoprolol for chronic congestive heart failure. Methods 92 patients with chronic congestive heart failure admitted during the period of January 2008 to December 2009 were randomly assigned to receive combination therapy with cardiac glycosides, diuretics, and ACE inhibitors (control group) or the combination therapy plus metoprolol (study group). The efficacy was compared between the two groups. Results 6 months after treatment, the study group was superior to the control group in efficacy (91.3% vs. 76.1% for total effective rate, P<0.05). Conclusions Metoprolol for chronic congestive heart failure can improve LVEF, LVDd, and LVPWT, resulting in a better clinical efficacy.
